Cargando…
Hepatitis C Virus Infection Influences the S-Methadone Metabolite Plasma Concentration
BACKGROUND AND OBJECTIVES: Heroin-dependent patients typically contract hepatitis C virus (HCV) at a disproportionately high level due to needle exchange. The liver is the primary target organ of HCV infection and also the main organ responsible for drug metabolism. Methadone maintenance treatment (...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720619/ https://www.ncbi.nlm.nih.gov/pubmed/23935979 http://dx.doi.org/10.1371/journal.pone.0069310 |
_version_ | 1782277976525635584 |
---|---|
author | Wu, Shiow-Ling Wang, Sheng-Chang Tsou, Hsiao-Hui Kuo, Hsiang-Wei Ho, Ing-Kang Liu, Sheng-Wen Hsu, Ya-Ting Chang, Yao-Sheng Liu, Yu-Li |
author_facet | Wu, Shiow-Ling Wang, Sheng-Chang Tsou, Hsiao-Hui Kuo, Hsiang-Wei Ho, Ing-Kang Liu, Sheng-Wen Hsu, Ya-Ting Chang, Yao-Sheng Liu, Yu-Li |
author_sort | Wu, Shiow-Ling |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: Heroin-dependent patients typically contract hepatitis C virus (HCV) at a disproportionately high level due to needle exchange. The liver is the primary target organ of HCV infection and also the main organ responsible for drug metabolism. Methadone maintenance treatment (MMT) is a major treatment regimen for opioid dependence. HCV infection may affect methadone metabolism but this has rarely been studied. In our current study, we aimed to test the hypothesis that HCV may influence the methadone dosage and its plasma metabolite concentrations in a MMT cohort from Taiwan. METHODS: A total of 366 MMT patients were recruited. The levels of plasma hepatitis B virus (HBV), HCV, human immunodeficiency virus (HIV) antibodies (Ab), liver aspartate aminotransferase (AST) and alanine aminotransferase (ALT), as well as methadone and its metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) were measured along with the urine morphine concentration and amphetamine screening. RESULTS: Of the 352 subjects in our cohort with HCV test records, 95% were found to be positive for plasma anti-HCV antibody. The liver functional parameters of AST (Wilcoxon Rank-Sum test, P = 0.02) and ALT (Wilcoxon Rank-Sum test, P = 0.04), the plasma methadone concentrations (Wilcoxon Rank-Sum test, P = 0.043) and the R-enantiomer of methadone concentrations (Wilcoxon Rank-Sum test, P = 0.032) were significantly higher in the HCV antibody-positive subjects than in the HCV antibody-negative patients, but not the S-EDDP/methadone dose ratio. The HCV levels correlated with the methadone dose ([Image: see text] = 14.65 and 14.13; P = 0.029 and 0.03) and the S-EDDP/methadone dose ratio ([Image: see text] = −0.41 and −0.40; P = 0.00084 and 0.002) in both univariate and multivariate regression analyses. CONCLUSIONS: We conclude that HCV may influence the methadone dose and plasma S-EDDP/methadone dose ratio in MMT patients in this preliminary study. |
format | Online Article Text |
id | pubmed-3720619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37206192013-08-09 Hepatitis C Virus Infection Influences the S-Methadone Metabolite Plasma Concentration Wu, Shiow-Ling Wang, Sheng-Chang Tsou, Hsiao-Hui Kuo, Hsiang-Wei Ho, Ing-Kang Liu, Sheng-Wen Hsu, Ya-Ting Chang, Yao-Sheng Liu, Yu-Li PLoS One Research Article BACKGROUND AND OBJECTIVES: Heroin-dependent patients typically contract hepatitis C virus (HCV) at a disproportionately high level due to needle exchange. The liver is the primary target organ of HCV infection and also the main organ responsible for drug metabolism. Methadone maintenance treatment (MMT) is a major treatment regimen for opioid dependence. HCV infection may affect methadone metabolism but this has rarely been studied. In our current study, we aimed to test the hypothesis that HCV may influence the methadone dosage and its plasma metabolite concentrations in a MMT cohort from Taiwan. METHODS: A total of 366 MMT patients were recruited. The levels of plasma hepatitis B virus (HBV), HCV, human immunodeficiency virus (HIV) antibodies (Ab), liver aspartate aminotransferase (AST) and alanine aminotransferase (ALT), as well as methadone and its metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) were measured along with the urine morphine concentration and amphetamine screening. RESULTS: Of the 352 subjects in our cohort with HCV test records, 95% were found to be positive for plasma anti-HCV antibody. The liver functional parameters of AST (Wilcoxon Rank-Sum test, P = 0.02) and ALT (Wilcoxon Rank-Sum test, P = 0.04), the plasma methadone concentrations (Wilcoxon Rank-Sum test, P = 0.043) and the R-enantiomer of methadone concentrations (Wilcoxon Rank-Sum test, P = 0.032) were significantly higher in the HCV antibody-positive subjects than in the HCV antibody-negative patients, but not the S-EDDP/methadone dose ratio. The HCV levels correlated with the methadone dose ([Image: see text] = 14.65 and 14.13; P = 0.029 and 0.03) and the S-EDDP/methadone dose ratio ([Image: see text] = −0.41 and −0.40; P = 0.00084 and 0.002) in both univariate and multivariate regression analyses. CONCLUSIONS: We conclude that HCV may influence the methadone dose and plasma S-EDDP/methadone dose ratio in MMT patients in this preliminary study. Public Library of Science 2013-07-23 /pmc/articles/PMC3720619/ /pubmed/23935979 http://dx.doi.org/10.1371/journal.pone.0069310 Text en © 2013 Wu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Wu, Shiow-Ling Wang, Sheng-Chang Tsou, Hsiao-Hui Kuo, Hsiang-Wei Ho, Ing-Kang Liu, Sheng-Wen Hsu, Ya-Ting Chang, Yao-Sheng Liu, Yu-Li Hepatitis C Virus Infection Influences the S-Methadone Metabolite Plasma Concentration |
title | Hepatitis C Virus Infection Influences the S-Methadone Metabolite Plasma Concentration |
title_full | Hepatitis C Virus Infection Influences the S-Methadone Metabolite Plasma Concentration |
title_fullStr | Hepatitis C Virus Infection Influences the S-Methadone Metabolite Plasma Concentration |
title_full_unstemmed | Hepatitis C Virus Infection Influences the S-Methadone Metabolite Plasma Concentration |
title_short | Hepatitis C Virus Infection Influences the S-Methadone Metabolite Plasma Concentration |
title_sort | hepatitis c virus infection influences the s-methadone metabolite plasma concentration |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720619/ https://www.ncbi.nlm.nih.gov/pubmed/23935979 http://dx.doi.org/10.1371/journal.pone.0069310 |
work_keys_str_mv | AT wushiowling hepatitiscvirusinfectioninfluencesthesmethadonemetaboliteplasmaconcentration AT wangshengchang hepatitiscvirusinfectioninfluencesthesmethadonemetaboliteplasmaconcentration AT tsouhsiaohui hepatitiscvirusinfectioninfluencesthesmethadonemetaboliteplasmaconcentration AT kuohsiangwei hepatitiscvirusinfectioninfluencesthesmethadonemetaboliteplasmaconcentration AT hoingkang hepatitiscvirusinfectioninfluencesthesmethadonemetaboliteplasmaconcentration AT liushengwen hepatitiscvirusinfectioninfluencesthesmethadonemetaboliteplasmaconcentration AT hsuyating hepatitiscvirusinfectioninfluencesthesmethadonemetaboliteplasmaconcentration AT changyaosheng hepatitiscvirusinfectioninfluencesthesmethadonemetaboliteplasmaconcentration AT liuyuli hepatitiscvirusinfectioninfluencesthesmethadonemetaboliteplasmaconcentration |